Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography

Journal of Biomolecular Techniques

Volumn 16, Issue 2, 2005, Pages 154-166

  Guzowski, Dorothy ^a   Chandrasekaran, Alamelu ^a   Gawel, Craig ^a   Palma, Jacqueline ^b   Koenig, Jonathan ^b   Wang, Xue Ping ^b   Dosik, Michael ^b   Kaplan, Mark ^b   Chu, Charles C ^a   Chavan, Sangeeta ^a   Furie, Richard ^a   Albesiano, Emilia ^b   Chiorazzi, Nicholas ^a   Goodwin, Leslie ^a  

^a North Shore LIJ Research Institute ^*  (United States)

^b NONE

Author keywords

cell chronic lymphocytic leukemia; Breast cancer; Denaturing high performance liquid chromatography; Promoter region of interleukin 10; Single nucleotide polymorphisms; Systemic erythematosus lupus

Indexed keywords

INTERLEUKIN 10;

ARTICLE; B CELL LEUKEMIA; BIOSYNTHESIS; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

BASE SEQUENCE; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; LEUKEMIA, B-CELL, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 33749542795     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13(6):198-200.
2. Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann T. Interleukin-10. Annu Rev Immunol 1993;11: 165-190.
3. Kim J, Braman C, Copeland NG, et al. Structure of mouse IL10 gene and chromosomal localization of mouse and human genes. J Immunol 1992;148: 3618-3623.
4. Lin Y, Wei SH, Ho AS, et al. Expression cloning and characterization of human IL10 receptor. J Immunol 1994;152:182-189.
5. Lalani I, Kailash B, Ahmed AR. Interleukin-10: Biology, role in inflammation and auto immunity. Ann Allergy Asthma Immunol 1997;79:469-481.
6. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19683-19765.
7. de Waal Malefyt R, Abrams J, Bennett B, et al. Il-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL10 by monocytes. J Exp Med 1991;174:1209-1220.
8. Cassatella MA, Meda L, Bonora-Aska M, Constantin G. Il-10 inhibits the release of proinflammatory cytokines from human polymorphonclear leukocytes. Evidence for an autocrine role of TNF and IL-1B in mediating the production of IL-8, triggered by lipopolysaccharide. J Exp Med 1993;178;2207-2211.
9. Rousset F, Garcia E, Defrance T, et al. IL-10 is a potent growth and differentiation factor for activated human lymphocytes. Proc Natl Acad Sci USA 1992;89: 1890-1893.
10. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T Helper cells IV. Th 2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 1989;170;2081-2095.
11. Tan JQ, Larsen GG, Gesser B, et al. Human IL-10 is a chemoattractant for CD8 and T lymphcytes and an inhibitor of IL-8 induced CD4+ T lymphocyte migration. J Immunol 1993;151:4545-4551.
12. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
13. Llorente L, Zou W, Levy Y, et al. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181:839-844.
14. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of IL4, IL10 and IL13 in patients with systemic sclerosis. J Rheumatol 1997;24:328-332.
15. Giordani L, Bruzzi P, Lasalandra C, et al. Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 2003; 49(10):1664-1667.
16. Tanjye SG, Weston KM, Raison RL. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+B-Cells. Leuk Lymphoma 1998;31(1-2): 121-130.
17. Lazarus M, Hajeer AH, Turner D. Genetic variation in interleukin 10 gene promoter and systemic lupus erythematous. J Rheumatol 1997;24(12):2314-2217.
18. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5'flanking region determine variable interleukin-10 transcription and Are Associated With Particular Phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42(6):1101-1108.
19. Westendorph RG, Langermans JA, Huizinga TW, Elousli AH, Verweij CL, Vandenbroucke, JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-174.
20. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
21. Eskdale J, Gallagher G, Verweij C, Keijsers V, Westendorp R, Huizinga T. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95:9465-9470.
22. Van der Linden MW, Westendorp RG, Sturk A, Bergman W, Huizinga TW. High interleukin-10 production in first-degree relatives of patients with generalized but no cutaneous lupus erythematosus. J Invest Med 2000;;48: 327-334.
23. Hoffmann SC, Stanley EM, Cox ED, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in Anti-Cd3/CD28-stimulated peripheral blood lymphocytes. 2001; Transplantation 2001;72:1444.
24. Suarez A, Castro P, Alonso R, Moso L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75(5):711-717.
25. NCBI SNP database-www.ncbi.nlm.nih.gov
26. Underhill PA, Jin L, Lin AA, et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 1997;7:996-1005.
27. Rudolph J, White S, Sokolsky C, et al. Determination of melting temperature for variant detection using dHPLC: A comparison between empirical determination and DNA melting prediction software. Genetic Testing 2002; 6(3):169-176.
28. Kube D, Platzer C, von Knethen A, et al. Isolation of human IL10 promoter. Characterization of promoter activity in Burkitt lymphoma cell lines. Cytokine 1995; 7:1-7.
29. Gibson A, Edberg J, Wei J, Westendorp R, Huisinga T, Kimberly R. Novel single nucleotide polymorphisms in distal IL-10 promoter affect IL-10 production and enhance risk of systemic lupus erythematosus. J Immunol 2001;166:3915-3922.
30. Beebe AM, Cua DJ, de Waal Malefyt R. Role of interleukin 10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002;13(4-5):403-412.
31. Rood MJ, Keijsers V, van der Linden MW, et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin-10 promoter haplotypes. Ann Rheum Dis 1999;58:85-89.
32. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090-1095.
33. Hoffman SC, Stanley EM, Cox ED, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002;2(6):560-567.
34. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25(11):1271-1277.
35. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997;50(6):669.
36. Mehrian R, Quismorio FP, Strassmann G, et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998;41(4):596-602.
37. Crawley E, Woo P, Isenberg D. Single nucleotide polymorphic haplotypes of the interleukin-10 5'flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:2017.
38. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393-395.
39. Llorente L, Richaud-Patin Y, Couderc J, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40:1429-435.
40. Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99:725-731.
41. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.
42. Hung MC, Lau, YK. Basic science of HER-2/neu: A review. Semin Oncol 1999;26(4 Suppl 12):51-59.
43. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM. Biological therapies for breast carcinoma: Concepts for improvement in survival. Semin Oncol 1999; 26(4 Suppl):28-40.
44. Temple SE, Lim E, Cheong KY, et al. Alleles carried at positions -819 and -591 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003;55(9):692-732.
45. Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewic MZ. Concentration of IL6, IL8 and IL10 in blood serum of breast cancer patients. Rocz Akad Med Bialymst 2003;48:82-84.
46. Toomey D, Harmey J, Condron C, Kay E, Bouchier-Hayes D. Phenotyping of immune cell infiltrates in breast and colorectal tumors. Immunol Invest 1999; 28(1):29-41.
47. Venetsanakos E, Beckman I, Bradley J, Skinner J. High incidence of interleukin-10 mRNA but not IL2 mRNA detected in breast tumors. Br J Cancer 1997;75(12): 1826-1830.
48. Mainou-Fowler T, Miller S, Proctor SJ, Dickinson AM. The levels of TNF alpha, IL4 and IL10 production by Tcell in B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Res 2001;25(2):157-163.
49. Jurlander J, Lai CF, Tan J, et al. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 1997;89(11): 4146-4152.
50. Yen Chong S, Lin YC, Czarneski J, et al. Cell cycle effects of Il-10 on malignant B-1 cells. Genes Immun 2001;2(5)239-247.
51. Sjoberg J, Aguilar-Santelises M, S Sjogren, et al. Interleukin- 10 mRNA expression in B-cell chronic lymphocytic leukemia inversely correlated with progression of disease. Br J Haematol 1996;92(2):393-400.
52. Damle R, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94(6): 1840-1847.
53. Wallace AJ. Combined single strand conformation polymorphism and heteroduplex analysis. In Taylor GR (ed): Laboratory Methods for Detection of Mutations and Polymorphisms in DNA. Boca Raton, Florida: CRC Press, 1997:79-94.
54. Kronick MN. Heterozygote determination using automated DNA sequencing technology. In Taylor GR (ed): Laboratory Methods for Detection of Mutations and Polymorphisms in DNA. Boca Raton, Florida: CRC Press, 1997:175-189.
55. Kennedy GC, Matsuzaki H, Dong S, et al. Large-scale genotyping of complex DNA. Nature Biotechnol 2003;21:1233-1237.
56. Matsuzaki H, Loi H, Dong S, et al. Parallel genotyping of over 10,000 SNPs using a one primer assay on a high density oligonucleotide array. Genome Res 2004;3: 414-425.
57. Liu WM, Di X, Yang G, et al. Algorithms for large scale genotyping microarrays. Bioinformatics 2003;19: 2397-2403.
58. Kuklin A, Munson K, Gjerde D, Haefele R, Taylor P. Detection of single-nucleotide polymorphisms with the WAVE™ DNA Fragment Analysis System. Genet Test 1998;1(3):201-206.
59. Spiegelman JI, Mindrinos MN, Oefner PJ. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques 2000;29:1084-1092.
60. Kuklin A, Davis AP, Hecker KH, Gjerde DT, Taylor PD. A novel technique for rapid automated genotyping of DNA polymorphisms in the mouse. Mol Cell Probes 1999;13(3):239-242.
61. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000:1:231-233.
62. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: On-line databases, Suppl. 1. Genes Immun 2001;2:61-70.
63. Patil N, Berno AJ, Hinds DA, et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001;294: 1719-1723.
64. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-228.
65. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001;29:229-232.
66. Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature 2001;411:199-204.
67. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
68. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-237.
69. Ke X, Cardon LR. Efficient selective screening of haplotype tag SNPs. Bioinformatics 2003;19(2):287-288.
70. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses using linkage disequilibrium and haplotypes. Am J Hum Genet 2003;73:115-130.
71. Zhang K, Deng M, Chen T, Waterman MS, Sun F.A Dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 2002;99:7335-7339.
72. Carlson C, Eberle M, Rieder M, Yi Q, Kruglyak L, Nickerson D. Selecting a maximally informative set of singlenucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74: 106-120.
73. Sebastiani P, Lazarus R, Weiss ST, Kunkel LM, Kohane IS, Ramoni MF. Minimal haplotype tagging. Proc Natl Acad Sci USA 2003;100:9900-9905.
74. Goldstein DB. Islands of linkage disequilibrium. Nat Genet 2001;29:109-111.